Effect of nicotine patch in Cognitive function improvement in Parkinson's disease
Not Applicable
Recruiting
- Conditions
- Parkinson's disease
- Registration Number
- JPRN-UMIN000016664
- Lead Sponsor
- Department of Clinical Pharmacology and Neurology Ehime University graduated School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
They received donepezil, galanthamine, administration of rivastigmine within study initiation two weeks. There was a change of the dose direction for use to an antiparkinson agent and the centrally acting drug (anxiolytics, antidepressants, anticonvulsant) taking. There is a remarkable disability in heart and the lungs liver renal function. The chief physician think the patient is inappropriate.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method score of the driving simulator
- Secondary Outcome Measures
Name Time Method Distribution ratio of alpha wave Trail Making Test